Glutamate is the major excitatory neurotransmitter in a mammal's central nervous system. It is an important component for neuroplasticity, the synaptic communication between neurons. It's also key to learning and memory. But in high concentrations, glutamate becomes toxic-- over-exciting the neurons. Glutamate-induced excitotoxicity is known to exacerbate damage caused by brain injury, stroke and other neurodegenerative diseases.

In order to understand possible ways to reduce the damage of excessive glutamate, researchers at Georgetown University Medical Center have shown how, when high concentrations of glutamate activate the metabotropic glutamate receptor 1 (mGlu1 receptors), they become protective. This concentration of glutamate is normally toxic.

The study, presented at the 39th annual meeting of the Society for Neuroscience, suggests that this glutamate-induced protection occurs due to the association of mGlu1 receptors with the intracellular protein β-arrestin, which causes a sustained phosphorylation of mitogen-activated protein kinases, and protects cells from apoptotic death.

"Studies about the signal transduction involved in mGlu1-mediated neuroprotection may enhance our understanding of the role that this glutamate receptor plays in brain injury," explains Andrew Emery, a PhD candidate in the Interdisciplinary Program in Neuroscience at GUMC. "Such studies may contribute to rational drug design for potential therapeutic approaches to protect against excitotoxic brain damage following injury, stroke and neurodegenerative diseases.

The study was funded by grants from the National Institute of Neurological Disorders and Stroke.

Note: If no author is given, the source is cited instead.

• Nervous System
• Amyotrophic Lateral Sclerosis
• Food Additives

• Brain Injury
• Multiple Sclerosis
• Disorders and Syndromes

• Excitotoxicity and cell damage
• Astrocyte
• Glutamic acid
• Neurotransmitter
• Dopamine hypothesis of schizophrenia
• Brain damage